Literature DB >> 14672910

Progressive multifocal leucoencephalopathy and immunosuppression.

L A Cuevas, H A Fuchs.   

Abstract

Mesh：

Year:  2004        PMID： 14672910      PMCID： PMC1754710     

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

2.  Case 15: when a stroke is not a stroke.

Authors:  W Bryan Burnette
Journal:  MedGenMed       Date:  2007-01-30

3.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.

Authors:  S Vulliemoz; F Lurati-Ruiz; F-X Borruat; J Delavelle; I J Koralnik; T Kuntzer; J Bogousslavsky; F Picard; T Landis; R A Du Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

4.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.